login
login
Image header Agence Europe
Europe Daily Bulletin No. 12693
EU RESPONSE TO COVID-19 / Health

European Medicines Agency confirms adverse effects of AstraZeneca vaccine without putting its effectiveness in question

The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) confirmed on Wednesday 7 April that the cases of thrombosis, accompanied by a low level of blood platelets, are indeed side effects of the Covid-19 vaccine produced by the Anglo-Swedish firm AstraZeneca.

This conclusion—which does not call into question the benefit-risk ratio of the product—had not been completely excluded in the previous analysis conducted by the EMA (see EUROPE B12681A2).

Contents

EU RESPONSE TO COVID-19
COUNCIL OF EUROPE
EXTERNAL ACTION
ECONOMY - FINANCE - BUSINESS
INSTITUTIONAL
SECTORAL POLICIES
NEWS BRIEFS